Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Expert Perspectives on the Rapid Expansion of Atopic Dermatitis Treatments
Raj Chovatiya, MD, PhD, and Neal Bhatia, MD, share their thoughts on the clinical implications of the rapid expansion of the atopic dermatitis treatment armamentarium.
Now Viewing
EP: 1.Expert Perspectives on the Rapid Expansion of Atopic Dermatitis Treatments
EP: 2.Atopic Dermatitis Treatment Biological Targets
EP: 3.Use of JAK Inhibitors in Clinical Practice
EP: 4.Importance of Clinical Trial Data, Disease Control, and QoL in Atopic Dermatitis Management
EP: 5.Final Thoughts for Atopic Dermatitis Treatment
EP: 6.Frontline Forum Part 1: A Discussion of the Current Treatment Landscape for Atopic Dermatitis
EP: 7.Frontline Forum Part 2: A Discussion of the Current Treatment Landscape for Atopic Dermatitis
EP: 8.Frontline Forum Part 3: A Discussion of the Current Treatment Landscape for Atopic Dermatitis
EP: 9.Frontline Forum Part 4: A Discussion of the Current Treatment Landscape for Atopic Dermatitis
EP: 10.Frontline Forum Part 5: A Discussion of the Current Treatment Landscape for Atopic Dermatitis
EP: 11.Expert Perspective on the Care of Patients with Atopic Dermatitis
EP: 12.Role of Disease Severity in Topical vs Systemic AD Treatment
EP: 13.Efficacy and Safety of JAK inhibitors for AD
EP: 14.Optimizing Patient Outcomes with JAK Inhibitors
Recent Videos
Related Content
